Results 101 to 110 of about 74,841 (314)

Exploring the psychosocial impact of undergoing botulinum toxin treatment

open access: yes, 2014
In 2012, the American Society for Plastic Surgeons reported that 13 million minimally invasive treatments, such as botulinum toxin injections and dermal fillers, were performed in the US.
Paraskeva, Nicole
core   +1 more source

Fifteen‐Year Outcomes of Bilateral Pallidal Stimulation in Isolated Generalized Dystonia: Characterization of Therapeutic Response and Emergence of Parkinsonism

open access: yesMovement Disorders, EarlyView.
Abstract Background Bilateral pallidal deep brain stimulation (GPi‐DBS) is effective for dystonia. Long‐term evolution of therapeutic benefit and emergence of parkinsonism have not been systematically characterized. Objectives To assess 15‐year dystonia outcomes and characterize parkinsonism after bilateral GPi‐DBS.
Clément Desjardins   +51 more
wiley   +1 more source

Botulinum Toxin Effects on Freezing of Gait in Parkinson’s Disease: A Systematic Review

open access: yesToxins
Freezing of gait is a frequent phenomenon and can be one of the most debilitating motor impairments in Parkinson’s disease, especially in the advanced stages.
Nicola Tambasco   +4 more
doaj   +1 more source

Vocal aging and adductor spasmodic dysphonia: Response to botulinum toxin injection

open access: yes, 2008
Michael P Cannito, Joel C Kahane, Lesya ChornaSchool of Audiology and Speech-Language Pathology, The University of Memphis, Memphis, TN, USAAbstract: Aging of the larynx is characterized by involutional changes which alter its biomechanical and neural ...
Lesya Chorna   +5 more
core   +1 more source

Botulinum Toxin [PDF]

open access: yes, 2009
Botulinum toxin is a neurotoxic protein produced by the bacterium Clostridium botulinum. Although botulinum toxin is the cause of the disease botulism and can be used in a terrorist attack, there are also many other uses for botulinum toxin.
Moshayev, David
core   +1 more source

Expanding the Phenotype of PARK‐PRKN to Spastic Paraplegia: A Report of Two Cases

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Nicolas Geoffre   +5 more
wiley   +1 more source

β3‐Adrenoceptor Agonists for Neurogenic Lower Urinary Tract Dysfunction: Evidence and Clinical Rationale for First‐Line Therapy

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Aims To summarize current evidence on β3‐adrenoceptor agonists for managing neurogenic lower urinary tract dysfunction (NLUTD), focusing on their efficacy, safety, and clinical role in optimizing bladder storage and protecting upper tracts. Methods Evidence from randomized controlled trials, meta‐analyses, and observational studies in spinal ...
Sharon E. Fishberg, Rano Matta
wiley   +1 more source

Clostridium botulinum

open access: yes, 2023
Tato práce se věnuje charakteristice bakterie Clostridium botulinum. Zaměřuje se na využití botulotoxinu v medicínské oblasti i kosmetickém průmyslu. Popisuje případy pacientů s botulismem a představuje diagnostické metody detekce Clostridium botulinum ...
Šestáková, Kateřina
core   +1 more source

Pharmacological Interaction of Botulinum Neurotoxins with Excitatory and Inhibitory Neurotransmitter Systems Involved in the Modulation of Inflammatory Pain

open access: yesToxins
Botulinum neurotoxins (BoNTs) are known to inhibit synaptic transmission by targeting SNARE proteins, but their selectivity toward central excitatory and inhibitory pathways is not yet fully understood. In this study, the interaction of serotypes A (BoNT/
Sara Marinelli   +2 more
doaj   +1 more source

Adverse Effects Linked to Counterfeit or Mishandled Botulinum Toxin Injections [PDF]

open access: yes
Distributed via the CDC Health Alert NetworkApril 23 2024, 11:00 AM ETCDCHAN-00507The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to alert clinicians about risks of counterfeit or mishandled

core  

Home - About - Disclaimer - Privacy